US Stock MarketDetailed Quotes

DHR Danaher

Watchlist
  • 199.390
  • +2.680+1.36%
Trading May 2 12:11 ET
142.70BMarket Cap38.64P/E (TTM)

About Danaher Company

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Company Profile

SymbolDHR
Company NameDanaher
Listing DateDec 10, 1969
Founded1984
CEOMr. Rainer M. Blair
MarketNYSE
Employees63000
Fiscal Year Ends12-31
Address2200 Pennsylvania Avenue North West,Suite 800 West
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20037-1701
Phone1-202-828-0850

Company Executives

  • Name
  • Position
  • Salary
  • Rainer M. Blair
  • Director, President and Chief Executive Officer
  • 22.11M
  • Matthew R. McGrew
  • Executive Vice President and Chief Financial Officer
  • 7.47M
  • Christopher M. Bouda
  • Vice President and Chief Accounting Officer
  • --
  • Dr. Jose-Carlos Gutierrez-Ramos, PhD
  • Senior Vice President and Chief Scientific Officer
  • 7.50M
  • Julie A. Sawyer Montgomery
  • Executive Vice President
  • --
  • Georgeann F. Couchara
  • Senior Vice President, Human Resources
  • 5.34M
  • R. Bradley Gray
  • Senior Vice President, Strategic Development
  • --
  • Daniel A. Raskas
  • Senior Vice President, Corporate Development
  • --
  • Christopher Paul Riley
  • Executive Vice President
  • --
  • Brian W. Ellis
  • Senior Vice President and General Counsel
  • 4.96M
  • Steven M. Rales
  • Chairman of the Board
  • --
  • Mitchell P. Rales
  • Director
  • --
  • Charles W. Lamanna
  • Independent Director
  • --
  • Professor Raymond C. Stevens, PhD
  • Independent Director
  • 328.98K
  • Teri L. List-Stoll
  • Independent Director
  • 328.98K
  • Linda Hefner Filler
  • Lead Independent Director
  • 391.48K
  • John T. Schwieters
  • Independent Director
  • 356.48K
  • Feroz Dewan
  • Independent Director
  • 328.98K
  • Alan G. Spoon, J.D.
  • Independent Director
  • 351.48K
  • A. Shane Sanders
  • Independent Director
  • 328.98K
  • Dr. Jessica L. Mega, M.D.,M.P.H.
  • Independent Director
  • 328.98K
  • Dr. Elias A. Zerhouni, M.D.
  • Independent Director
  • 351.48K

Market Insights

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.